A Case of Tumoral Calcinosis in a Hemodialysis Patient with Secondary Hyperparathyroidism

Tumoral calcinosis is a periarticular calcific lesion and rare complication in patients with maintenance hemodialysis. The pathogenesis of tumoral calcinosis is poorly understood but may be due to elevated serum phosphorus, a high calcium phosphorus (Ca×P) product or secondary hyperparathyroidism in hemodialysis patients. A 30-year-old man presented with pain and palpable mass of left shoulder. He had been on maintenance hemodialysis with high flux dialyzer for 10 years. Laboratory finding showed hyperphosphatemia and elevated intact PTH concentration. A shoulder X-ray and CT scan demonstrated a massive calcification. Following partial resection, pain was relieved. Here we report a case of tumoral calcinosis of shoulder in a hemodialysis patient with untreated hyperphosphatemia and secondary hyperparathyroidism.

[1]  M. Younes,et al.  Complete reversal of tumoral calcinosis after subtotal parathyroidectomy in a hemodialysis patient. , 2008, Joint, bone, spine : revue du rhumatisme.

[2]  V. Aggarwal,et al.  Tumoral calcinosis (Teutschlander disease) in a dialysis patient , 2008, Indian journal of nephrology.

[3]  J. Hamada,et al.  Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits. , 2006, The Journal of rheumatology.

[4]  M. Gigante,et al.  Resolution of tumoral calcinosis in a hemodialysis patient using low calcium dialysate. , 2005, Joint, bone, spine : revue du rhumatisme.

[5]  W. Goodman,et al.  Worsening of soft tissue calcifications in a hemodialysis patient following parathyroidectomy , 2004, Hemodialysis international. International Symposium on Home Hemodialysis.

[6]  R. Ravanan,et al.  Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  F. Port,et al.  Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  F. Oppenheimer,et al.  Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy. , 1999, The Journal of rheumatology.

[9]  K. Lynn,et al.  Rapid resolution of tumoral calcinosis after renal transplantation. , 1999, Clinical nephrology.

[10]  Š. Alušík,et al.  Tumoral calcinosis in a dialysis patient , 1998 .

[11]  Y. Doi,et al.  Sintered carbonate apatites as bioresorbable bone substitutes. , 1998, Journal of biomedical materials research.

[12]  M. Hatori,et al.  Hydroxyapatite crystals in tumoral calcinosis: a case report. , 1996, The Tohoku journal of experimental medicine.

[13]  S. Norton,et al.  PROPOSAL FOR A PATHOGENESIS‐BASED CLASSIFICATION OF TUMORAL CALCINOSIS , 1996, International journal of dermatology.

[14]  K. Stamatelou,et al.  Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. , 1996, Nephron.

[15]  Q. Duh,et al.  Tumoral calcinosis. Controversies in the etiology and alternatives in the treatment. , 1993, Archives of surgery.

[16]  J. Zingraff,et al.  Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication. , 1992, Nephron.

[17]  D. Sherrard,et al.  Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.